Flindr Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $21.8M

  • Investors
  • 10

Flindr Therapeutics General Information

Description

Developer of a biotech platform intended to develop precision immuno-oncology treatments. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and is building a pipeline of Immunotherapies, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.

Contact Information

Website
www.flindrtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kloosterstraat 9
  • Pivot Park
  • 5349 AB Oss
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kloosterstraat 9
  • Pivot Park
  • 5349 AB Oss
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flindr Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 28-Mar-2024 $21.8M Completed Pre-Clinical Trials
2. Seed Round 01-Nov-2021 Completed Pre-Clinical Trials
1. Seed Round 01-Sep-2020 Completed Startup
To view Flindr Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Flindr Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotech platform intended to develop precision immuno-oncology treatments. The company is engaged in deve
Drug Discovery
Oss, Netherlands
10 As of 2025

Oxford, United Kingdom
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Flindr Therapeutics Competitors (70)

One of Flindr Therapeutics’s 70 competitors is Oxford Biotherapeutics, a Private Equity-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Quell Therapeutics Venture Capital-Backed London, United Kingdom
Xenetic Biosciences Corporation Framingham, MA
Anaveon Venture Capital-Backed Basel, Switzerland
Aulos Venture Capital-Backed Larkspur, CA
You’re viewing 5 of 70 competitors. Get the full list »

Flindr Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Flindr Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024404420-A1 Compounds Pending 22-Dec-2023
EP-4828022-A1 Compounds Pending 22-Dec-2023
GB-202319887-D0 Compounds Active 22-Dec-2023
GB-2636825-A Compounds Active 22-Dec-2023
GB-2636825-B Compounds Active 22-Dec-2023 C07D215/54
To view Flindr Therapeutics’s complete patent history, request access »

Flindr Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Flindr Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flanders Future Techfund Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Qbic Fund Venture Capital Minority
V-Bio Ventures Venture Capital Minority
VIB Not-For-Profit Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Flindr Therapeutics FAQs

  • When was Flindr Therapeutics founded?

    Flindr Therapeutics was founded in 2020.

  • Where is Flindr Therapeutics headquartered?

    Flindr Therapeutics is headquartered in Oss, Netherlands.

  • What is the size of Flindr Therapeutics?

    Flindr Therapeutics has 10 total employees.

  • What industry is Flindr Therapeutics in?

    Flindr Therapeutics’s primary industry is Drug Discovery.

  • Is Flindr Therapeutics a private or public company?

    Flindr Therapeutics is a Private company.

  • What is Flindr Therapeutics’s current revenue?

    The current revenue for Flindr Therapeutics is .

  • How much funding has Flindr Therapeutics raised over time?

    Flindr Therapeutics has raised $21.8M.

  • Who are Flindr Therapeutics’s investors?

    Flanders Future Techfund, Johnson & Johnson JJDC, Qbic Fund, V-Bio Ventures, and VIB are 5 of 10 investors who have invested in Flindr Therapeutics.

  • Who are Flindr Therapeutics’s competitors?

    Oxford Biotherapeutics, Quell Therapeutics, Xenetic Biosciences, Anaveon, and Aulos are some of the 70 competitors of Flindr Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process